VERA insider transactions

SEC Form 4 filed by Director Morrison Scott W

SEC Form 4 filed by Director Cheng Andrew

SEC Form 4 filed by Director Seidenberg Beth C

SEC Form 4 filed by Director Oliger Christy J.

SEC Form 4 filed by Director Meyers James R

SEC Form 4 filed by Director Hall Kimball

SEC Form 4 filed by Director Morrissey Michael

SEC Form 4 filed by Director Enright Patrick G

PRESIDENT AND CEO Fordyce Marshall sold $679,747 worth of shares (18,500 units at $36.74) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 216,744 units (SEC Form 4)

SEC Form 4 filed by Fordyce Marshall

SEC Form 4 filed by Wright-Mitchell Jane

SEC Form 3 filed by new insider Wright-Mitchell Jane

SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R exercised 10,000 shares at a strike of $3.94, increasing direct ownership by 15% to 75,754 units (SEC Form 4)

SEC Form 4 filed by Director Hite Christopher

SEC Form 3 filed by new insider Hite Christopher

Chief Medical Officer Brenner Robert sold $90,307 worth of shares (2,151 units at $41.98), decreasing direct ownership by 4% to 50,947 units (SEC Form 4)

SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R sold $130,864 worth of shares (3,117 units at $41.98), decreasing direct ownership by 5% to 64,722 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Grant Sean sold $207,778 worth of shares (4,949 units at $41.98), decreasing direct ownership by 4% to 114,181 units (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall sold $710,578 worth of shares (16,925 units at $41.98), decreasing direct ownership by 6% to 257,163 units (SEC Form 4)

Chief Operating Officer Johnson David Lee sold $108,276 worth of shares (2,579 units at $41.98), decreasing direct ownership by 5% to 45,727 units (SEC Form 4)

Chief Regulatory Officer Turner William D. sold $91,819 worth of shares (2,187 units at $41.98), decreasing direct ownership by 5% to 45,313 units (SEC Form 4)

Chief Commercial Officer Skelton Laurence Matthew sold $66,419 worth of shares (1,582 units at $41.98), decreasing direct ownership by 2% to 64,218 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Grant Sean was granted 25,000 shares, increasing direct ownership by 27% to 119,130 units (SEC Form 4)

SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R was granted 10,000 shares, increasing direct ownership by 17% to 67,839 units (SEC Form 4)

Chief Commercial Officer Skelton Laurence Matthew was granted 20,000 shares, increasing direct ownership by 44% to 65,800 units (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall was granted 68,800 shares, increasing direct ownership by 34% to 274,088 units (SEC Form 4)

Chief Operating Officer Johnson David Lee was granted 20,000 shares, increasing direct ownership by 71% to 48,306 units (SEC Form 4)

Chief Regulatory Officer Turner William D. was granted 25,000 shares, increasing direct ownership by 111% to 47,500 units (SEC Form 4)

Chief Medical Officer Brenner Robert was granted 25,000 shares, increasing direct ownership by 89% to 53,098 units (SEC Form 4)

New insider Skelton Laurence Matthew claimed ownership of 45,800 shares (SEC Form 3)

Chief Regulatory Officer Turner William D. exercised 10,000 shares at a strike of $15.53 and sold $500,767 worth of shares (10,000 units at $50.08) (SEC Form 4)

Director Enright Patrick G bought $249,985 worth of shares (5,882 units at $42.50) (SEC Form 4)

Chief Regulatory Officer Turner William D. exercised 10,000 shares at a strike of $15.53 and sold $453,053 worth of shares (10,000 units at $45.31) (SEC Form 4)

Chief Regulatory Officer Turner William D. exercised 10,000 shares at a strike of $15.53 and sold $400,000 worth of shares (10,000 units at $40.00) (SEC Form 4)

SEC Form 4 filed by Director Meyers James R

SEC Form 3 filed by new insider Meyers James R

Chief Legal Officer Carter Jason S sold $107,498 worth of shares (3,864 units at $27.82), decreasing direct ownership by 7% to 49,136 units (SEC Form 4)

SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R sold $435,874 worth of shares (15,000 units at $29.06) and exercised 10,000 shares at a strike of $3.94, decreasing direct ownership by 8% to 57,839 units (SEC Form 4)

Director Enright Patrick G bought $5,277,311 worth of shares (250,000 units at $21.11) (SEC Form 4)

SEC Form 4 filed by Director Katabi Maha

SEC Form 4 filed by Director Enright Patrick G

SEC Form 4 filed by Director Oliger Christy J.

SEC Form 4 filed by Director Morrissey Michael

SEC Form 4 filed by Director Seidenberg Beth C

SEC Form 4 filed by Director Hall Kimball

SEC Form 4 filed by Director Morrison Scott W

SEC Form 4 filed by Director Cheng Andrew

PRESIDENT AND CEO Fordyce Marshall sold $546,914 worth of shares (19,688 units at $27.78), decreasing direct ownership by 9% to 204,665 units (SEC Form 4)

SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R was granted 10,740 shares, increasing direct ownership by 21% to 61,946 units (SEC Form 4)

Chief Development Officer Turner William D. was granted 22,500 shares (SEC Form 4)

Chief Medical Officer Brenner Robert was granted 26,900 shares, increasing direct ownership by 4,686% to 27,474 units (SEC Form 4)

CHIEF FINANCIAL OFFICER Grant Sean was granted 26,900 shares, increasing direct ownership by 41% to 93,237 units (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall was granted 80,750 shares, increasing direct ownership by 56% to 224,353 units (SEC Form 4)

Chief Operating Officer Johnson David Lee was granted 26,900 shares (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall exercised 17,500 shares at a strike of $2.90 and sold $730,535 worth of shares (17,500 units at $41.74) (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall exercised 75,161 shares at a strike of $2.90 and sold $753,680 worth of shares (17,500 units at $43.07), increasing direct ownership by 67% to 143,603 units (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall exercised 17,500 shares at a strike of $2.90 and sold $821,523 worth of shares (17,500 units at $46.94) (SEC Form 4)

PRESIDENT AND CEO Fordyce Marshall exercised 19,375 shares at a strike of $2.90 and sold $929,560 worth of shares (19,375 units at $47.98) (SEC Form 4)

Chief Legal Officer Carter Jason S was granted 53,000 shares (SEC Form 4)

SEC Form 3 filed by new insider Carter Jason S